Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016073

Chief Legal Officer gave up 4,779 shares (to pay taxes)

  • Chief Legal Officer acquired 17,175 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2020-03-02 Option exercise +17,175 103,978 D
Ali-Jackson Kamil Chief Legal Officer 2020-03-02 Shares withheld for taxes −4,779 $1.26 $6,022 99,199 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2020-03-02 Option exercise · Restricted stock units −17,175 51,525 D
Ali-Jackson Kamil Chief Legal Officer 2020-03-02 Grant or award · Employee Stock Option (Right to Buy) +92,928 92,928 D
Ali-Jackson Kamil Chief Legal Officer 2020-03-02 Grant or award · Restricted stock units +66,377 66,377 D
Ali-Jackson Kamil Chief Legal Officer 2020-03-02 Grant or award · Restricted stock units +26,551 26,551 D
Loading xslF345X03/doc4.xml…